EcoDrugPlus

Integrin Subunit Alpha 5

Ensembl ID : ENSSFOG00015018245
Gene Symbol: ITGA5
1 Cross references
197 Possible Orthologues:

Integrin Subunit Alpha V

Ensembl ID : ENSSFOG00015002170
Gene Symbol: ITGAV
3 Cross references
236 Possible Orthologues:

Integrin Subunit Beta 1

Ensembl ID : ENSSFOG00015016121
Gene Symbol: ITGB1
3 Cross references
297 Possible Orthologues:

Integrin Subunit Beta 1

Ensembl ID : ENSSFOG00015005810
Gene Symbol: ITGB1
3 Cross references
297 Possible Orthologues:

Integrin Subunit Beta 3

Ensembl ID : ENSSFOG00015011898
Gene Symbol: ITGB3
3 Cross references
194 Possible Orthologues:

Integrin Subunit Beta 5

Ensembl ID : ENSSFOG00015021737
Gene Symbol: ITGB5
3 Cross references
210 Possible Orthologues:

Integrin Subunit Beta 6

Ensembl ID : ENSSFOG00015022954
Gene Symbol: ITGB6
3 Cross references
206 Possible Orthologues:

Integrin Subunit Beta 8

Ensembl ID : ENSSFOG00015012748
Gene Symbol: ITGB8
3 Cross references
202 Possible Orthologues:

Integrin, Alpha 2b

Ensembl ID : ENSSFOG00015021092
Gene Symbol: ITGA2B
1 Cross references
190 Possible Orthologues:

Integrin, Alpha V

Ensembl ID : ENSSFOG00015012155
Gene Symbol: ITGAV
1 Cross references
236 Possible Orthologues:

Interleukin 1 Receptor Associated Kinase 4

Ensembl ID : ENSSFOG00015005625
Gene Symbol: IRAK4
3 Cross references
202 Possible Orthologues:

Inward Rectifier Potassium Channel 2-Like

Ensembl ID : ENSSFOG00015004808
Gene Symbol: LOC108924858
3 Cross references
207 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).